These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 39206992

  • 21. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y, Yu M, Yang JX, Cao DY, Zhang Y, Shen K, You Y.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec 25; 53(12):816-822. PubMed ID: 30585019
    [Abstract] [Full Text] [Related]

  • 22. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec 25; 47(12):928-33. PubMed ID: 23324194
    [Abstract] [Full Text] [Related]

  • 23. Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.
    Mueller JJ, Holzapfel M, Han CH, Santos K, Gunderson C, Moore K, Erickson B, Leath CA, Diaz E, Walsh C, Wethington SL, Dejbakhsh SZ, Barakat RR, Gardner GJ, Hyman DM, Soslow RA, Leitao MM.
    Int J Gynecol Cancer; 2016 Jan 25; 26(1):120-4. PubMed ID: 26509849
    [Abstract] [Full Text] [Related]

  • 24. Significance of lymphovascular space invasion in epithelial ovarian cancer.
    Matsuo K, Sheridan TB, Yoshino K, Miyake T, Hew KE, Im DD, Rosenshein NB, Mabuchi S, Enomoto T, Kimura T, Sood AK, Roman LD.
    Cancer Med; 2012 Oct 25; 1(2):156-64. PubMed ID: 23342265
    [Abstract] [Full Text] [Related]

  • 25. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H, Takeda M, Fujimoto T, Todo Y, Ebina Y, Watari H, Yamamoto R, Minakami H, Sakuragi N.
    Gynecol Oncol; 2004 Jul 25; 94(1):161-6. PubMed ID: 15262135
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N, Yamada H, Oikawa M, Okuyama K, Fujino T, Sagawa T, Fujimoto S.
    Gynecol Oncol; 2000 Nov 25; 79(2):251-5. PubMed ID: 11063653
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Factor affecting lymph node metastasis in uterine papillary serous carcinomas: a retrospective analysis.
    Tutkun Kilinc EC, Korkmaz V, Yalcin HR.
    J Obstet Gynaecol; 2022 Nov 25; 42(8):3725-3730. PubMed ID: 36927276
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Survival impact of low anterior resection in patients with epithelial ovarian cancer grossly confined to the pelvic cavity: a Korean multicenter study.
    Kim M, Suh DH, Park JY, Paik ES, Lee S, Eoh KJ, Nam JH, Lee YY, Kim JW, Kim S.
    J Gynecol Oncol; 2018 Jul 25; 29(4):e60. PubMed ID: 29770630
    [Abstract] [Full Text] [Related]

  • 33. The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.
    Deng T, Huang Q, Wan T, Luo X, Feng Y, Huang H, Liu J.
    J Gynecol Oncol; 2021 May 25; 32(3):e40. PubMed ID: 33825356
    [Abstract] [Full Text] [Related]

  • 34. Impact of lymph node staging in presumed early-stage ovarian carcinoma.
    Rodrigues Teixeira F, Vertematti de Castro V, Chaves Faloppa C, Mantoan H, Yuri Kumagai L, Narcizo Oliveira Menezes A, Badiglian-Filho L, De Brot L, Tirapelli Goncalves B, Paiva Gadelha Guimaraes A, Baiocchi G.
    Eur J Obstet Gynecol Reprod Biol; 2022 Nov 25; 278():6-10. PubMed ID: 36108452
    [Abstract] [Full Text] [Related]

  • 35. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V, Kocaer M, Çakır İ, Özdemir İA, Sancı M, Güngördük K.
    J Obstet Gynaecol; 2020 Jul 25; 40(5):699-704. PubMed ID: 31607197
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancer.
    Kleppe M, van der Aa MA, Van Gorp T, Slangen BF, Kruitwagen RF.
    Eur J Cancer; 2016 Oct 25; 66():83-90. PubMed ID: 27536891
    [Abstract] [Full Text] [Related]

  • 38. Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
    Ayhan A, Aslan K, Öz M, Tohma YA, Kuşçu E, Meydanli MM.
    Arch Gynecol Obstet; 2019 Sep 25; 300(3):675-682. PubMed ID: 31263988
    [Abstract] [Full Text] [Related]

  • 39. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
    Yan M, Zhang YN, He JH, Sun JR, Sun XM.
    Chin J Cancer; 2010 Apr 25; 29(4):425-30. PubMed ID: 20346220
    [Abstract] [Full Text] [Related]

  • 40. Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.
    Matsuo K, Wong KK, Fotopoulou C, Blake EA, Robertson SE, Pejovic T, Frimer M, Pardeshi V, Hu W, Choi JS, Sun CC, Richmond AM, Marcus JZ, Hilliard MAM, Mostofizadeh S, Mhawech-Fauceglia P, Abdulfatah E, Post MD, Saglam O, Shahzad MMK, Karabakhtsian RG, Ali-Fehmi R, Gabra H, Roman LD, Sood AK, Gershenson DM.
    J Surg Oncol; 2018 Feb 25; 117(2):236-244. PubMed ID: 28787528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.